3D Biotech Innovation 
Crunchbase News
JUNE 7, 2024
tied) Prolific Machines , $55M, biotech: Unlike in previous weeks, there was no huge biotech round. tied) Restor3d , $55M, 3D technology: Restor3d, a North Carolina-based maker of 3D printed personalized orthopedic implants, locked up a $70 million financing — even as investors continue to cool on 3D tech startups.
CIO
APRIL 17, 2024
Similarly, clothing brand Under Armour recently produced an ad that used AI-generated 3D models of the British boxer Anthony Joshua, based on videos they took of him in the past. The victors may not be the greatest innovators, but they’ll be the best at protecting their innovations.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
TechCrunch
APRIL 6, 2022
Printing me softly with his song : Mostly known for its battery packs, Anker launches a Kickstarter campaign for its first 3D printer. 6 questions investors should ask when evaluating psychedelic biotech companies. 6 questions investors should ask when evaluating psychedelic biotech companies. You can sign up here.).
TechCrunch
FEBRUARY 9, 2021
Yet, the R&D process for drug discovery relies on 2D monitors, keyboard, and mouse, which limits the understanding of complex 3D structures or interactions and contributes to massive R&D costs averaging $2.5B “Understanding structure empowers our users to understand how their designs function,” he wrote in an email. per drug.”.
Crunchbase News
SEPTEMBER 13, 2024
Biotech and AI had another strong week, as the sectors saw two big nine-figure rounds each — including one for $370 million in biotech. Candid Therapeutics , $370M, biotech: Every week there’s a big biotech raise — and this week there’s one that’s really big. Check out last week’s biggest funding rounds here.
Crunchbase News
AUGUST 13, 2024
Healthcare/biotech companies took the lead with three companies that joined the board from this sector. Google Ventures , US Innovative Technology Fund , General Catalyst , Founders Fund , Caffeinated Capital and angel investor Elad Gil each have two portfolio companies across this cohort. Who invested?
TechCrunch
JUNE 10, 2022
“That’s really where we have innovated: we have built DragonFold, which is the first protein-ligand co-folding algorithm,” said Laskh Aithani, CEO and co-founder of Charm Therapeutics. “Designing drugs that bind to the disease-causing protein of interest very tightly and selectively (i.e.,
Expert insights. Personalized for you.
126 
Let's personalize your content